Kailera
Nasdaq KLRA · Waltham, MA
Works in Metabolic & endocrine · Renal & urogenital · Women's health
Kailera is a clinical trial sponsor based in Waltham, MA, listed as Nasdaq KLRA. It has 6 active clinical trials with 5,672 planned participants, in Metabolic & endocrine, Renal & urogenital and Women's health. Since 2021 it has completed 2 trials and stopped 0 early.
Trial track record · since 2021
Financials · Nasdaq KLRA
Fundraising
Pipeline · 6 active trials
| Stage | Trial | Status |
|---|---|---|
Questions about Kailera
Kailera is lead sponsor of 6 active clinical trials on ClinicalTrials.gov, with 5,672 planned participants, in Metabolic & endocrine, Renal & urogenital, Women's health. Since 2021 it has completed 2 trials and stopped 0 early.
Kailera is based in Waltham, MA and is listed as Nasdaq KLRA. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Kailera; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-10-06.
Approve Suite is not affiliated with Kailera.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.